J. Ro¨hrling et al. / Carbohydrate Research 337 (2002) 691–700
699
n-hexane–EtOAc); UV: umax 230 nm (m 5.8×105 dm2/
mol, MeOH); Fluorescence: uexc 290 nm, uem 344 nm
[DMAc/LiCl 0.9% (m/v)]; IR (KBr): w 1724 (CꢀN); H
H-4%), 3.57 (dd, 1 H, J5%,6b% 5.3, J6a%,6b% 11.4 Hz, H-6b%),
3.46 (dd, 1 H, J5%,6a% 7.0, H-6a%), 3.42 (s, 3 H, 1%-OMe),
and 3.29 (s, 3 H, 4%-OMe); 13C NMR (CD3OD): l
156.09 (CꢀO), 155.03 (C-3%), 139.39 (C-1), 127.94 (C-4),
126.47 (C-6), 123.64 (C-3), 120.96 (C-2), 115.37 (C-5),
103.80 (C-1), 80.75 (C-5%), 79.04 (C-4%), 76.92 (CH2ON),
74.79 (CH2ON), 70.77 (CH2OCH2), 70.71 (CH2OCH2),
66.51 (C-2%), 63.10 (C-6%), 57.10 (4%-OMe), and 56.52
(1-OMe); MALDI-TOF MS: m/z 540.25 [M+Na]+.
Anal. Calcd for C25H31N3O9: C, 58.02; H, 6.04; N, 8.12.
Found: C, 57.72; H, 5.93; N, 7.88.
1
NMR (CDCl3): l 9.17 (br. s, 1 H, NH), 8.13 (d, 2 H,
J4,5 8.3 Hz, H-5), 8.00 (d, 2 H, J2,3 7.7 Hz, H-2), 7.49
(ddd, 2 H, J2,4 1.2, J3,4 7.9, J4,5 8.3 Hz, H-4), 7.34 (dd,
2 H, J3,5 0.9 Hz, H-3), 7.30–7.20 (m, 5 H, Ph), 4.52–
4.42 (m, 4 H, H-1%, H-2%, CH2Ph), 4.36–4.27 (m, 4 H, 2
CH2ON), 4.13 (ddd, 1 H, J4%,5% 1.5, J5%,6a% 8.4, J5%,6b% 4.8
Hz, H-5%), 3.90–3.69 (m, 6 H, CH2OCH2, H-4%), 3.51
(dd, 1 H, J6a%,6b% 9.9 Hz, H-6b%), 3.42 (dd, 1 H, H-6b%),
3.32 (s, 3 H, 4%-OMe), and 3.14 (s, 3 H, 1%-OMe); 13C
NMR (CDCl3): l 153.99, 153.76 (CꢀO, C-3), 137.94,
137.84 (C-1, Ph), 128.36 (Ph), 127.69 (Ph), 127.60 (Ph),
127.12 (C-4), 125.38 (C-6), 122.73 (C-3), 119.95 (C-2),
114.55 (C-5), 101.81 (C-1%), 77.56 (C-4%), 77.16 (C-5%),
75.85 (CH2ON), 73.35 (CH2Ph), 72.89 (CH2ON), 69.99
(CH2OCH2), 69.70, 69.60 (C-6%, CH2OCH2), 65.53 (C-
2%) 56.54 (4%-OMe), and 56.38 (1%-OMe); MALDI-TOF
MS: m/z 631.54 [M+Na]+. Anal. Calcd for
C32H39N3O9: C, 63.04; H, 6.45; N, 6.89. Found: C,
63.20; H, 6.29; N, 6.68.
Methyl i-D-gluco-hexodialdo-1,5-pyranoside {7-
[(9H-9-carbazolylcarbonyl)amino]-1,4,7-trioxaheptyl}-
imine (23).—Compound 12 (10.0 mg, 0.048 mmol) and
20 (87.0 mg, 0.24 mmol) were reacted according to the
general procedure. Final purification by chromatogra-
phy (93:7 CH2Cl2–MeOH) gave 23 (E-isomer) as color-
less crystals (22.2 mg, 93%): mp 170–172 °C (MeOH);
[h]2D0 −29° (c 0.3, MeOH); Rf 0.27 (93:7 CH2Cl2–
MeOH); UV: umax 231 nm (m 5.0×105 dm2/mol,
MeOH); Fluorescence: uexc 290 nm, uem 346 nm
1
[DMAc/LiCl 0.9% (m/v)]; IR (KBr): w 1674 (CꢀN); H
Methyl 4-O-methyl-i-D-ribo-hex-3-ulopyranoside {7-
NMR (d6-Me2SO): l 11.50 (br. s, 1 H, NH), 8.18 (d, 2
H, J2,3 7.7 Hz, H-2), 8.00 (d, 2 H, J4,5 8.4 Hz, H-5), 7.51
(dd, 2 H, J3,4 8.4 Hz, H-4), 7.36 (dd, 2 H, H-3), 7.36 (d,
1 H, J5%,6% 7.3 Hz, H-6%), 5.14 (d, 2 H, J 4.9 Hz, 2 OH),
5.08 (d, 1 H, J 4.1 Hz, OH), 4.19–4.13 (m, 5 H, H-1%,
2 CH2ON), 3.80–3.66 (m, 5 H, CH2OCH2, H-5%), 3.36
(s, 3 H, OMe), 3.23–3.10 (m, 2 H, H-3%, H-4%), and
3.05–2.94 (m, 1 H, H-2%); 13C NMR (d6-Me2SO): l
152.82 (CꢀO), 148.71 (C-6%), 137.66 (C-1), 126.76 (C-4),
124.13 (C-6), 122.06 (C-3), 120.18 (C-2), 114.09 (C-5),
104.03 (C-1%), 75.94 (C-3%), 75.01 (CH2ON), 73.18 (C-5%,
C-2%), 72.73 (CH2ON), 71.57 (C-4%), 68.75 (CH2OCH2),
68.60 (CH2OCH2), and 56.18 (1%-OMe); MALDI-TOF
MS: m/z 527.69 [M+Na]+.
[(9H-9-carbazolylcarbonyl)-amino]-1,4,7-trioxaheptyl}-
imine (22).—Compound 10 (7.0 mg, 0.034 mmol) and
20 (62.0 mg, 0.17 mmol) were reacted according to the
general procedure. Final purification by chromatogra-
phy (19:1 CH2Cl2–MeOH) gave 23 (E-isomer) as a
colorless oil (4.8 mg, 27%): [h]2D0 −25° (c 0.4, MeOH);
Rf 0.35 (19:1 CH2Cl2–MeOH); UV: umax 230 nm (m
5.9×105 dm2/mol, MeOH); Fluorescence: uexc 290 nm,
uem 346 nm [DMAc/LiCl 0.9% (m/v)]; IR (KBr): w 1701
1
(CꢀN); H NMR (CD3OD): l 8.10–8.04 (m, 4 H, H-2,
H-5), 7.49 (ddd, 2 H, J3,4 7.9, J4,5 8.3, J2,4 1.2 Hz, H-4),
7.34 (ddd, 2 H, J2,3 7.7, J2,4 1.0 Hz, H-3), 4.73 (dd, 1 H,
H-4%), 4.71 (d, 1 H, J1%,2% 2.9 Hz, H-1%), 4.35–4.29 (m, 2
H, CH2ON), 4.26–4.21 (m, 2 H, CH2ON), 3.96–3.80
(m, 6 H, CH2OCH2, H-2%, H-5%), 3.53 (d, 2 H, J5%,6% 6.3
Hz, H-6%), 3.41 (s, 3 H, 1%-OMe), and 3.38 (s, 3 H,
4%-OMe); 13C NMR (CD3OD): l 156.09 (CꢀO), 153.31
(C-3%), 139.47 (C-1), 127.94 (C-4), 126.46 (C-6), 123.61
(C-3), 120.96 (C-2), 115.36 (C-5), 105.34 (C-1%), 79.30
(C-5%), 76.94 (CH2ON), 74.68 (CH2ON), 72.04 (C-2%),
71.15 (C-4%), 70.77 (CH2OCH2), 63.12 (C-6%), 57.93
(4%-OMe), and 56.76 (1%-OMe); MALDI-TOF MS: m/z
540.73 [M+Na]+.
Further elution gave 23 (Z-isomer) as a colorless
solid: (0.9 mg, 4%): Rf 0.20 (93:7 CH2Cl2–MeOH); UV:
1
umax 231 nm (m 4.5×105 dm2/mol, MeOH); H NMR
(CD3OD): l 8.08 (d, 2 H, J4,5 8.5 Hz, H-5), 8.07 (d, 2
H, J2,3 7.9 Hz, H-2), 7.48 (dd, 2 H, J3,4 8.5 Hz, H-4),
7.33 (dd, 2 H, H-3), 6.70 (d, 1 H, J5%,6% 6.8 Hz, H-6%),
4.55 (dd, 1 H, J4%,5% 9.2 Hz, H-5%), 4.28 (t, 2 H, J 4.5 Hz,
CH2ON), 4.23 (t, 2 H, J 4.5 Hz, CH2ON), 4.14 (d, 1 H,
J1%,2% 7.8 Hz, H-1%), 3.89 (t, 2 H, CH2OCH2), 3.83 (t, 2
H, CH2OCH2), 3.46 (s, 3 H, OMe), 3.34–3.29 (m, 1 H,
H-3%), 3.24 (dd, 1 H, J3%,4% 9.2 Hz, H-4%), and 3.12 (dd, 1
H, J2%,3% 8.1 Hz, H-2%); 13C NMR (CD3OD): l 153.25
(CꢀO), 149.33 (C-6%), 127.78 (C-4), 126.23 (C-6), 123.18
(C-3), 120.90 (C-2), 115.24 (C-5), 105.48 (C-1), 77.45
(C-3%), 76.32 (CH2ON), 74.93 (C-2%), 74.69 (CH2ON),
73.79 (C-4%), 70.88 (CH2OCH2), 70.71 (CH2OCH2),
69.06 (C-5%), and 57.47 (1-OMe); MALDI-TOF MS:
m/z 527.53 [M+Na]+. Further elution (17:3 CH2Cl2–
MeOH) gave unchanged 20 (50 mg, 57%).
Further elution gave 22 (Z-isomer) as a colorless oil
(8.6 mg, 49%): [h]2D0 +8° (c 0.4, MeOH); Rf 0.29 (19:1
CH2Cl2–MeOH); UV: umax 230 nm (m 5.9×105 dm2/
mol, MeOH); Fluorescence: uexc 290 nm, uem 346nm
1
[DMAc/LiCl 0.9% (m/v)]; IR (KBr): w 1706 (CꢀN); H
NMR (CD3OD): l 8.10–8.04 (m, 4 H, H-5, H-2), 7.48
(ddd, 2 H, J3,4 7.4, J4,5 7.4, J2,4 1.2 Hz, H-4), 7.35 (ddd,
2 H, J2,3 8.0, J3,5 1.0 Hz, H-3), 4.59 (d, 1 H, J1%,2% 6.1 Hz,
H-1%), 4.47 (d, 1 H, H-2%), 4.34 (m, 2 H, CH2ON), 4.25
(m, 2 H, CH2ON), 3.95–3.79 (m, 6 H, CH2OCH2, H-5%,